IS CELL DEATH IN PARKINSONíS DISEASE REALLY APOPTOSIS?
Ozansoy M, Basak AN*
*Corresponding Author: A. Nazli Basak, Bogaziçi University, Department of Molecular Biology and Genetics, 34342, Bebek, Istanbul, Turkey; Tel.: +90-212-359-66-79; Fax: +90-212-287-24-68; E-mail: basak@boun.edu.tr
page: 3

REFERENCES

1. Gasser T. Genetics of Parkinsonís Disease. J Neurol 2001; 248(10): 833-840.

      2. Ahlskog JE. Diagnosis and differential diagnosis of Parkinsonís Disease and Parkinsonism. Parkinsonism Relat Disord 2001; 7(1): 63-70.

      3. Przedborski S. Pathogenesis of nigral cell death in Parkinsonís Disease. Parkinsonism Relat Disord 2005; 11(1): S3-S7.

      4. Ameisen JC. On the origin, evolution, and nature of programmed cell death: a timeline of four billion years. Cell Death Differ 2002; 9(4): 367-393.

      5. Philchenkov A. Caspases: potential targets for regu­lating cell death. J Cell Mol Med 2004; 8(4): 432-444.

      6. Riedl SJ, Shi Y. Molecular mechanisms of caspase regulation during apoptosis. Nat Molec Cell Biol 2004; 5(11): 897-907.

      7. Green DR. Apoptotic pathways: ten minutes to dead. Cell 2005; 121(5): 671-674.

      8. Green DR. Apoptotic pathways: paper wraps stone blunts scissors. Cell 2000; 102(1): 1-4.

      9. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X. Cytochrome c and dATP-dependent formation of APAF-1/Caspase-9 com­plex initiates an apoptotic protease cascade. Cell 1997; 91(4): 479-489.

      10. Bossy-Wetzel E, Green DR. Caspases induce cyto­chrome c release from mitochondria by activating cyto­solic factors. TJ Biol Chem 1999; 274(25): 17484-17490.

      11. Danial NN, Korsmeyer SJ. Cell death: critical control points. Cell 2004; 116(2): 205-219.

      12. Hirsch EC, Hunot S, Faucheux B, Agid Y. Dopa­minergic neurons degenerate by apoptosis in Parkinsonís Disease. Mov Disord 1999; 14(2): 383-384.

      13. Banati R, Blunt S, Graeber MB. What does apop­tosis have to do with Parkinsonís Disease. Mov Disord 1999; 14(2): 384-385.

      14. Mogi M, Togari A, Kondo T, Mizuno Y, Komure O, Kuno S, Ichinose H, Nagatsu T. Caspase activities and tumor necrosis factor receptor R1 (p55) level are elevated in the substantia nigra from Parkinsonian brain. J Neural Transm 2000; 107(3): 335-341.

      15. Vila M, Jackson-Lewis V, Vukosavic S, Djaldetti R, Liberatore G, Offen D, Korsmeyer SJ, Przedborski S. Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinsonís Disease. Proc Natl Acad Sci USA 2001; 98(5): 2837-2842.

      16. Hayakawa M, Hayakawa H, Migita M, Shibata M, Tanaka R, Suzuki A, Shimo-Nakanishi Y, Urabe T, Yamada M, Tamayose K, Shimada T, Miura M, Mizuno Y. An AAV-derived APAF-1 dominant negative inhibitor prevents MPTP toxicity as antiapoptotic gene therapy for Parkinsonís Disease. Proc Natl Acad Sci USA 2001; 98(19): 10918-10923.

      17. Gorman AM, Szegezdi E, Quigney DJ, Samali A. Hsp27 inhibits 6-hydroxydopamine-induced cytochrome c release and apoptosis in PC12 cells. Biochem Biophys Res Commun 2005; 327(3): 801-810.

      18. Biswas SC, Ryu E, Park C, Malagelada C, Greene LA. Puma and p53 play required roles in death evoked in a cellular model of Parkinsonís Disease. Neurochem Res 2005; 30(6-7): 839-845.

      19. Perier C, Tieu K, Guégan C, Caspersen C, Jackson-Lewis V, Carelli V, Martinuzzi A, Hirano M, Przedborski S, Vila M. Complex I deficiency primes bax-dependent neuronal apoptosis through mitochondrial oxi­dative damage. Proc Natl Acad Sci USA 2005; 102(52): 19126-19131.

      20. Xu J, Zhong N, Wang H, Elias JE, Kim CY, Woldman I, Pifl C, Gygi SP, Geula C, Yankner BA. The Parkinsonís Disease-associated DJ-1 protein is a transcrip­tional co-activator that protects against neuronal apoptosis. Hum Molec Genet 2005; 14(9): 1231-1241.

      21. Petit A, Kawarai T, Paitel E, Sanjo N, Maj M, Scheid M, Chen F, Gu Y, Hasegawa H, Salehi-Rad S, Wang L, Rogaeva E, Fraser P, Robinson B, St George-Hyslop P, Tandon A. Wild-type PINK1 prevents basal and induced neuronal apoptosis, a protective effect abrogated by Parkinson Disease-related mutations. J Biol Chem 2005; 280(40): 34025-34032.

            22. Maraganore DM, Andrade M, Lesnick TG, Strain KJ, Farrer MJ, Rocca WA, Krishna Pant PV, Frazer KA, Cox DR, Ballinger DG. High-resolution whole-genome association study of Parkinson Disease. Am J Hum Genet 2005; 77(5): 685-693.



Number 23
VOL. 23, 2020 Acepted articles
Number 22
VOL. 22(2), 2019
Number 22
VOL. 22(1), 2019
Number 22
VOL. 22, 2019 Accepted articles
Number 22
VOL. 22, 2019 Supplement
Number 21
VOL. 21(2), 2018
Number 21
VOL. 21 (1), 2018
Number 21
VOL. 21, 2018 Accepted articles
Number 21
VOL. 21, 2018 Supplement
Number 20
VOL. 20 (2), 2017
Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006